Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

		Phase:		Phase 1

		Treatment ID#:		1871

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		10/09/2008

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma


		Comments:		Taxol is a drug that is effective for many cancers including breast and lung to name two. It works very well at killing brain tumor cells in a dish, but lacks the ability to get across the blood brain barrier to work effectively in patients. This study utilizes a 15 amnio acid peptide which is a ligand for a receptor that actively transports across the blood brain barrier, as well as into certain tumor cells like glioblastoma. The peptide has three molecules of taxol conjugated.

		Treatment Type:		Chemotherapy

		Contact:		Clinical Trials Office - Dana-Farber/Harvard Cancer Center Dana-Farber/Harvard Cancer Center Dana Farber Cancer Institute Boston, MA 02115 USA Phone: 617-582-8480 Fax: E-mail: Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By